SS Innovations International (SSII) Income from Continuing Operations (2016 - 2026)
SS Innovations International (SSII) posted Income from Continuing Operations of 3582571.0 for Q1 2026, down 165.34% sequentially from 5482964.0 in Q4 2025, and up 20.18% YoY from 2981023.5 in Q1 2025.
SS Innovations International (SSII) Income from Continuing Operations (2016 - 2026) Analysis & Trends
SS Innovations International has reported Income from Continuing Operations for 11 years, with the latest figure at 3582571.0 in Q1 2026.
- Quarterly Income from Continuing Operations rose 20.18% year-over-year to 3582571.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 2074262.0 (down 180.5% YoY) and the FY2025 annual result came in at 8180947.0, down 1052.11% from the prior year.
- Income from Continuing Operations retreated to 3582571.0 in Q1 2026 per SSII's latest filing, from 5482964.0 in the prior quarter.
- Over five years, Income from Continuing Operations peaked at 12899882.0 in Q4 2024 and troughed at 9592378.0 in Q4 2023.
- A 5-year average of 1534698.88 and a median of 1499845.0 in 2023 frame the typical range for Income from Continuing Operations.
- The sharpest annual moves came in 2023 and 2024: Income from Continuing Operations sank 1189.82% in 2023, then soared 234.48% in 2024.
- Over 5 years, Income from Continuing Operations stood at 998076.0 in 2022, then tumbled by 861.09% to 9592378.0 in 2023, then jumped by 234.48% to 12899882.0 in 2024, then slumped by 57.5% to 5482964.0 in 2025, then sank by 165.34% to 3582571.0 in 2026.
- According to Business Quant data, Income from Continuing Operations over the past three periods registered 3582571.0, 5482964.0, and 3717964.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.51 Bn | 194.91 Bn | 7.27 Bn | 928.00 Mn |
| 2 | Stryker | 129.96 Bn | 126.48 Bn | 4.50 Bn | 1.28 Bn |
| 3 | Medtronic | 120.18 Bn | 110.96 Bn | 6.41 Bn | 1.26 Bn |
| 4 | Boston Scientific | 74.28 Bn | 73.74 Bn | 3.85 Bn | 905.00 Mn |
| 5 | Edwards Lifesciences | 52.75 Bn | 48.50 Bn | 1.35 Bn | 241.40 Mn |
| 6 | Dexcom | 34.67 Bn | 32.73 Bn | 830.00 Mn | 249.10 Mn |
| 7 | GE HealthCare Technologies | 34.23 Bn | 32.12 Bn | 2.18 Bn | 574.00 Mn |
| 8 | Koninklijke Philips | 26.46 Bn | 23.14 Bn | 4.55 Bn | 1.04 Bn |
| 9 | Steris | 23.30 Bn | 22.82 Bn | 684.20 Mn | 201.00 Mn |
| 10 | SS Innovations International | 698.47 Mn | 676.18 Mn | 7.10 Mn | -2.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -2.66 Mn |
| Mar 31, 2026 | -3.58 Mn |
| Dec 31, 2025 | 5.48 Mn |
| Sep 30, 2025 | -3.72 Mn |
| Jun 30, 2025 | -256,691.00 |
| Mar 31, 2025 | -4.49 Mn |
| Dec 31, 2024 | 12.90 Mn |
| Sep 30, 2024 | -2.56 Mn |
| Jun 30, 2024 | -3.27 Mn |
| Mar 31, 2024 | -7.77 Mn |
| Dec 31, 2023 | -9.59 Mn |
| Sep 30, 2023 | -1.50 Mn |
| Jun 30, 2023 | -4.36 Mn |
| Mar 31, 2023 | -1.04 Mn |
| Dec 31, 2022 | -998,076.00 |
| Sep 30, 2022 | -456,494.00 |
| Jun 30, 2022 | -788,423.00 |
| Mar 31, 2022 | -80,421.00 |
| Dec 31, 2021 | -352,956.00 |
| Sep 30, 2021 | -418,209.00 |